
In spite of his rising name in the horror scene, he failed to convince the studios to take a chance with Repo!. When Bousman enjoyed his success with the tremendous Saw sequels, one project remained at the back of his mind – what he, Smith, and Zdunich had accomplished years before. Who knew that his filmmaking career would blow up in such a huge way just 3 years later? Talk about how the stars aligned. They put their trust in the then 23-year-old to bring their dream to life, despite him having no major directing credit under his belt. A serendipitous encounter led them to Darren Lynn Bousman. In 2002, Smith and Zdunich finally began their search for a director to stage a full-length play based on their brainchild. Then known as The Necromerchant’s Debt, it lasted all of 10 minutes and still charmed audiences in its short duration. Back in the 90s when their partnership began, they had launched Repo! as a scaled down rock club performance. How far had the pair come since their first meeting at an acting class. Their zeal is music to the ears of screen/songwriters Darren Smith and Terrance Zdunich, who often show up at these shows in appreciation. Echoes of “Testify!” rose as they arrived in theatres, decked out in character costumes, performing shadow casts of their favourite scenes before the screen as recent as last year. Some fans are practically worshippers of the unholy union.

Repo! The Genetic Opera managed to find a large cult following, gathering to savour macabre murders and soaring voices in opera alike. Gorehounds may very well scoff at the idea of enjoying the Broadway experience, while musical fans are just as likely to balk at the hungry scalpels’ excessive bloodshed, which make the Demon Barber of Fleet Street seem tame next to it.īut everybody’s got somebody.

On paper, it is hard to imagine any measure of success for a film that puts music to this near-future dystopia. This post is part of Preamble to Halloween, an October marathon of horror features before the dawn of All Hallows’ Eve.ĭuring a worldwide epidemic, biotech corporation Geneco forces millions to purchase costly organs in order to survive. Darren Lynn Bousman, 2008) – During an epidemic of organ failures, a biotech company emerges with the antidote of transplants – for a price.
